Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will ...

(INO) shares plummeted 28.34% Monday after the biotech company announced that the U.S. Food and Drug Administration (FDA) had put its COVID-19 vaccine on hold until it answers further questions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In rare cases, hepatitis B can lead to life-threatening complications like liver failure, liver cancer, or cirrhosis (liver scarring). The hepatitis B vaccine is a shot, typically injected into the ...

Vaccines are a clinical product that is composed of live or dead material from an infectious agent – bacterium, virus, fungus or parasite – that elicit protective immunity against the pathogen ...

Andrade, Cashman et al. evaluate varying immunization regimens of INO-4500, a DNA-based vaccine for Lassa fever, in non-human primates. INO-4500 induces humoral and cellular immune responses ...

Covid vaccines saved lives. Lots of them. Research by the World Health Organization (WHO) now puts the number at 475,000 in the UK with many more kept out of hospital or off a ventilator.

Wing Commander Clive Beadon’s collection of medals was sold on Wednesday morning by Noonans Mayfair for £4,800. His son, John Beadon, put in a bid of £2,400 for the collection, which included ...

2024年，奇瑞年营收首次达到4800亿元，同比增长超过50%，实现了年增长超1500亿的大跨越。虽然净利润还没有被公布，但奇瑞透露，净资产收益率（ROE ...

INOVIO Pharmaceuticals, Inc., the Plymouth Meeting-based pharmaceutical company, will test the first dose of its COVID-19 vaccine today on a healthy volunteer. “This is a significant step ...

Babies are supposed to receive vaccines that protect against about 15 different infectious diseases. Most require more than one dose, which amounts to nearly 30 jabs by age two. Parents may be ...